双重GIP和GLP-1受体激动剂的体重减轻和健康风险改善的视觉证明。

IF 3.8 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Sophia Ramirez, Ryan Yang, Muhammed Habibovic, Samantha Kennedy, Jonathan P Bennett, John A Shepherd, Diana M Thomas, Steven B Heymsfield
{"title":"双重GIP和GLP-1受体激动剂的体重减轻和健康风险改善的视觉证明。","authors":"Sophia Ramirez, Ryan Yang, Muhammed Habibovic, Samantha Kennedy, Jonathan P Bennett, John A Shepherd, Diana M Thomas, Steven B Heymsfield","doi":"10.1038/s41366-025-01842-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Body weight and health-outcome results of highly effective new GLP-1R agonist medicine trials are usually presented in scientific reports in the form of standard graphs and tables. These representations are not easily translated to what the average participant looked like or their health risks at the outset of the study and how improvements in adiposity and clinical measures changed with treatment. Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports. The current study aim was to put these visual presentations into a demonstration format to explore if and to what extent they convey new or useful information beyond traditional graphical and tabular approaches.</p><p><strong>Methods: </strong>The first developed approach was the capability of generating, with manifold regression, humanoid avatars with accurate anthropometric dimensions. The second developed approach, body roundness index (BRI), associates a person's shape phenotype with high-risk adiposity components and multiple health outcomes; BRI can be displayed in a visual format. These two approaches were applied to produce visual representations of body size and shape in Surmount 1 average male and female participants (maximal-tolerated dose group) at baseline and after 72-weeks of tirzepatide treatment.</p><p><strong>Results: </strong>Developed images revealed clear excess adiposity and high health-risk (BRI) at baseline with marked improvements, although not to within the healthy BMI (<25 kg/m<sup>2</sup>) and BRI ranges at 72 weeks, observations not evident in the published report. Avatar analyses revealed sexual dimorphism in regional shape (volume) changes with weight loss.</p><p><strong>Conclusions: </strong>Visual presentation of new weight loss medicine trial results can supplement standard published reports by condensing substantial amounts of complex technical information in an easily understood format that can potentially yield new study insights.</p>","PeriodicalId":14183,"journal":{"name":"International Journal of Obesity","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist.\",\"authors\":\"Sophia Ramirez, Ryan Yang, Muhammed Habibovic, Samantha Kennedy, Jonathan P Bennett, John A Shepherd, Diana M Thomas, Steven B Heymsfield\",\"doi\":\"10.1038/s41366-025-01842-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Body weight and health-outcome results of highly effective new GLP-1R agonist medicine trials are usually presented in scientific reports in the form of standard graphs and tables. These representations are not easily translated to what the average participant looked like or their health risks at the outset of the study and how improvements in adiposity and clinical measures changed with treatment. Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports. The current study aim was to put these visual presentations into a demonstration format to explore if and to what extent they convey new or useful information beyond traditional graphical and tabular approaches.</p><p><strong>Methods: </strong>The first developed approach was the capability of generating, with manifold regression, humanoid avatars with accurate anthropometric dimensions. The second developed approach, body roundness index (BRI), associates a person's shape phenotype with high-risk adiposity components and multiple health outcomes; BRI can be displayed in a visual format. These two approaches were applied to produce visual representations of body size and shape in Surmount 1 average male and female participants (maximal-tolerated dose group) at baseline and after 72-weeks of tirzepatide treatment.</p><p><strong>Results: </strong>Developed images revealed clear excess adiposity and high health-risk (BRI) at baseline with marked improvements, although not to within the healthy BMI (<25 kg/m<sup>2</sup>) and BRI ranges at 72 weeks, observations not evident in the published report. Avatar analyses revealed sexual dimorphism in regional shape (volume) changes with weight loss.</p><p><strong>Conclusions: </strong>Visual presentation of new weight loss medicine trial results can supplement standard published reports by condensing substantial amounts of complex technical information in an easily understood format that can potentially yield new study insights.</p>\",\"PeriodicalId\":14183,\"journal\":{\"name\":\"International Journal of Obesity\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Obesity\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41366-025-01842-1\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Obesity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41366-025-01842-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:高效的新型GLP-1R激动剂药物试验的体重和健康结局结果通常以标准图表的形式出现在科学报告中。这些表征并不容易转化为研究开始时平均参与者的长相或他们的健康风险,以及肥胖和临床措施的改善如何随着治疗而改变。最近开发的两种方法可以直观地呈现复杂的体重和健康风险信息,这些信息包含了大量的临床试验观察结果,可以潜在地补充和提供传统GLP-1R激动剂科学报告的新见解。目前的研究目的是将这些视觉呈现形式转化为演示形式,以探索它们是否以及在多大程度上传达了超越传统图形和表格方法的新的或有用的信息。方法:首先开发的方法是利用流形回归生成具有精确人体尺寸的人形化身的能力。第二种发展起来的方法是身体圆度指数(BRI),它将一个人的形状表型与高风险的肥胖成分和多种健康结果联系起来;BRI可以以可视化的形式显示。这两种方法被应用于在基线和替西帕肽治疗72周后,对平均男性和女性参与者(最大耐受剂量组)的身体大小和形状进行视觉表征。结果:发达的图像显示,在基线时明显的过度肥胖和高健康风险(BRI)有明显的改善,尽管在72周时不在健康的BMI(2)和BRI范围内,观察结果在已发表的报告中不明显。Avatar分析显示,随着体重减轻,区域形状(体积)的变化呈现两性二态性。结论:新的减肥药试验结果的可视化呈现可以通过以易于理解的格式浓缩大量复杂的技术信息来补充标准发表的报告,从而可能产生新的研究见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist.

Background: Body weight and health-outcome results of highly effective new GLP-1R agonist medicine trials are usually presented in scientific reports in the form of standard graphs and tables. These representations are not easily translated to what the average participant looked like or their health risks at the outset of the study and how improvements in adiposity and clinical measures changed with treatment. Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports. The current study aim was to put these visual presentations into a demonstration format to explore if and to what extent they convey new or useful information beyond traditional graphical and tabular approaches.

Methods: The first developed approach was the capability of generating, with manifold regression, humanoid avatars with accurate anthropometric dimensions. The second developed approach, body roundness index (BRI), associates a person's shape phenotype with high-risk adiposity components and multiple health outcomes; BRI can be displayed in a visual format. These two approaches were applied to produce visual representations of body size and shape in Surmount 1 average male and female participants (maximal-tolerated dose group) at baseline and after 72-weeks of tirzepatide treatment.

Results: Developed images revealed clear excess adiposity and high health-risk (BRI) at baseline with marked improvements, although not to within the healthy BMI (<25 kg/m2) and BRI ranges at 72 weeks, observations not evident in the published report. Avatar analyses revealed sexual dimorphism in regional shape (volume) changes with weight loss.

Conclusions: Visual presentation of new weight loss medicine trial results can supplement standard published reports by condensing substantial amounts of complex technical information in an easily understood format that can potentially yield new study insights.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Obesity
International Journal of Obesity 医学-内分泌学与代谢
CiteScore
10.00
自引率
2.00%
发文量
221
审稿时长
3 months
期刊介绍: The International Journal of Obesity is a multi-disciplinary forum for research describing basic, clinical and applied studies in biochemistry, physiology, genetics and nutrition, molecular, metabolic, psychological and epidemiological aspects of obesity and related disorders. We publish a range of content types including original research articles, technical reports, reviews, correspondence and brief communications that elaborate on significant advances in the field and cover topical issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信